These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1379 related items for PubMed ID: 8757191

  • 1. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ.
    J Natl Cancer Inst; 1996 Aug 21; 88(16):1118-26. PubMed ID: 8757191
    [Abstract] [Full Text] [Related]

  • 2. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 May 21; 14(5):1262-9. PubMed ID: 15894683
    [Abstract] [Full Text] [Related]

  • 3. The role of sex hormone-binding globulin (SHBG), testosterone, and other sex steroids, on the development of type 2 diabetes in a cohort of community-dwelling middle-aged to elderly men.
    Gyawali P, Martin SA, Heilbronn LK, Vincent AD, Taylor AW, Adams RJT, O'Loughlin PD, Wittert GA.
    Acta Diabetol; 2018 Aug 21; 55(8):861-872. PubMed ID: 29845345
    [Abstract] [Full Text] [Related]

  • 4. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM, Huang WY, Rinaldi S, Fears TR, Chatterjee N, Hsing AW, Crawford ED, Andriole GL, Kaaks R, Hayes RB.
    Int J Cancer; 2008 May 15; 122(10):2345-50. PubMed ID: 18172860
    [Abstract] [Full Text] [Related]

  • 5. Androgens and prostate cancer risk: a prospective study.
    Wirén S, Stocks T, Rinaldi S, Hallmans G, Bergh A, Stenman UH, Kaaks R, Stattin P.
    Prostate; 2007 Aug 01; 67(11):1230-7. PubMed ID: 17562541
    [Abstract] [Full Text] [Related]

  • 6. Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III).
    Rohrmann S, Nelson WG, Rifai N, Kanarek N, Basaria S, Tsilidis KK, Smit E, Giovannucci E, Platz EA.
    Urology; 2007 Apr 01; 69(4):708-13. PubMed ID: 17445656
    [Abstract] [Full Text] [Related]

  • 7. Circulating steroid hormones and the risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan 01; 15(1):86-91. PubMed ID: 16434592
    [Abstract] [Full Text] [Related]

  • 8. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 9. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 18; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 10. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.
    Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A.
    Br J Cancer; 2016 Apr 12; 114(8):939-44. PubMed ID: 26986253
    [Abstract] [Full Text] [Related]

  • 11. Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population.
    Gustafsson O, Norming U, Gustafsson S, Eneroth P, Aström G, Nyman CR.
    Br J Urol; 1996 Mar 12; 77(3):433-40. PubMed ID: 8814852
    [Abstract] [Full Text] [Related]

  • 12. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR.
    J Natl Cancer Inst; 1996 Aug 21; 88(16):1127-35. PubMed ID: 8757192
    [Abstract] [Full Text] [Related]

  • 13. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 14. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
    Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhenn IA, Levine PH, Hsing AW, Cook MB.
    Prostate; 2017 Dec 20; 77(16):1573-1582. PubMed ID: 28971497
    [Abstract] [Full Text] [Related]

  • 15. Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004.
    Nyante SJ, Graubard BI, Li Y, McQuillan GM, Platz EA, Rohrmann S, Bradwin G, McGlynn KA.
    Int J Androl; 2012 Jun 20; 35(3):456-66. PubMed ID: 22150314
    [Abstract] [Full Text] [Related]

  • 16. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
    Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A, Lenner P.
    Cancer Causes Control; 2003 Sep 20; 14(7):599-607. PubMed ID: 14575357
    [Abstract] [Full Text] [Related]

  • 17. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.
    Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, Dobs AS, Kanarek N, Nelson WG, Platz EA.
    Prostate; 2015 Aug 01; 75(11):1167-76. PubMed ID: 25919471
    [Abstract] [Full Text] [Related]

  • 18. Influence of radical prostatectomy on serum hormone levels.
    Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC.
    J Urol; 1998 Aug 01; 160(2):449-53. PubMed ID: 9679896
    [Abstract] [Full Text] [Related]

  • 19. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
    Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ.
    J Natl Cancer Inst; 2008 Feb 06; 100(3):170-83. PubMed ID: 18230794
    [Abstract] [Full Text] [Related]

  • 20. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
    Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, Chu LW, Patel SK, Thompson IM, Reichardt JK, Hoque A, Platz EA, Figg WD, Van Bokhoven A, Lippman SM, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2012 Oct 06; 21(10):1823-32. PubMed ID: 22879203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.